News

Category: Advancements in Alzheimer’s disease

LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER’S DISEASE

Eisai Co., Ltd. - Sept 27 2022

Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease

F. Hoffmann-La Roche Ltd - June 16, 2022

Blood test for Alzheimer’s highly accurate in large, international study

The Source, Washington University in St. Louis - Feb 22, 2022

Dementia First blood test to help diagnose Alzheimer’s goes on sale

AP News - November 30, 2020

Why Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease

New York Times - Nov 4 2019

‘Reports of My Death Are Greatly Exaggerated.’ Signed, Aducanumab

Alzforum - Oct 24 2019

The importance of prevention trials in Alzheimer’s disease with Randall Bateman

Neuro Central, September 23, 2019

Blood test is highly accurate at identifying Alzheimer’s before symptoms arise

Washington University School of Medicine, August 2, 2019